The Quest MPS 3 System allows surgeons to take myocardial protection to the next level. Experience enhanced safety, accuracy and control with Quest MPS Technology.
Experience the evolution of control and accuracy.
The Quest MPS 3 System has redefined the induction dose with its all new feature – Auto Start. Innovative technology for myocardial protection allows for fast aortic valve closure. Targeted parameters of flow and pressures, set within the Active Monitoring Controller (AMC). The Quest MPS 3 System quickly initiates and auto-regulates ramp-up reaching targeted values for a fast and safe arrest – the most effective induction dose possible, all with the touch of a button.
Compliance with Any Protocol
ANY RATIO, ANY STRATEGY,
All parameters are easily and quickly adjustable during the case, providing accurate and agile control for better myocardial protection.
Real Time Data Collection
The Quest MPS 3 System, captures and records all drug volumes and concentrations, in real time. The agility of the system allows for changes any time during the procedure. The console and freestanding controller work in unison to provide accurate and safe delivery of arrest and additive agents, no matter which cardioplegia protocol you prefer.
Better Patient Care and Outcomes
The Quest MPS 3 System is a powerful tool for the cardiovascular team and, with detailed data analytics, promotes better patient care.
The Quest Strategy for Confident Myocardial Protection.
Microplegia is the pure blood initiative, a whole blood alternative to traditional blood-crystalloid cardioplegia. It provides superior myocardial protection without dilution, using the patient’s own blood as the most physiologic buffer, and lowers transfusion rates3. Only Quest MPS Technology delivers precision microplegia by independent control of additive and arrest agents.